Prevention of calcific aortic valve stenosis-fact or fiction? (Q37249445)

19 August 2017

1 reference

title

Prevention of calcific aortic valve stenosis-fact or fiction? (English)

1 reference

19 August 2017

0 references

Catherine M Otto

2

0 references

author name string

Peter J Cawley

series ordinal

1

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

41

1 reference

19 August 2017

issue

2

1 reference

19 August 2017

page(s)

100-108

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

19 August 2017

1 reference

T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Echocardiographic prevalence of bicuspid aortic valve in the population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Induction of local angiotensin II-producing systems in stenotic aortic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Increased expression of elastolytic cathepsins S, K, and V and their inhibitor cystatin C in stenotic aortic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Rationale, design, and baseline characteristics of a randomized trial to assess the effect of cholesterol lowering on the progression of aortic stenosis: the Aortic Stenosis Progression Observation: Measuring Effects of Rosuvastatin (ASTRONOMER) tri

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Methods and limitations of assessing new noninvasive tests: part I: Anatomy-based validation of noninvasive testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Survival benefits of angiotensin-converting enzyme inhibitors in older heart failure patients with perceived contraindications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Frequency of Bicuspid Aortic Valve in Young Male Conscripts by Echocardiogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890802331394

10.1080/07853890802331394

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference